We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Articulating Tissue Sealer Provides Stronger Seal

By HospiMedica International staff writers
Posted on 19 Feb 2013
An advanced articulating energy device enables surgeons to achieve stronger sealing and better access. More...


The EnSeal G2 articulating tissue sealer is designed to allow surgeons to take a perpendicular approach to seal blood vessels and lymphatics of up to 7 mm in diameter, through a standard 5-mm port. The articulation helps surgeons maneuver around corners and behind structures in the body, and provide better access to tissue in deep or tight spaces for greater control of the angle of approach to vessels. Moreover, since vessels sealed perpendicularly are stronger than those sealed at oblique angles, the likelihood of internal bleeding and postsurgery complications is reduced.

The EnSeal G2 system builds on proprietary I-BLADE technology, which delivers high uniform compression for sealing vessels consistently along the length of the device jaw, providing superior tissue sealing. The proprietary electrode configuration is designed to minimize thermal spread into surrounding tissue by using positive temperature coefficient technology and an offset electrode configuration to control energy spread. The EnSeal G2 articulating tissue sealer is a product of Ethicon Endo-Surgery (Ethicon; Cincinnati, OH, USA).

“EnSeal G2 Articulating builds on an existing portfolio of advanced bipolar tissue sealers designed to give surgeons confidence and choice in surgery,” said Joe Amaral, MD, Ethicon Chief Scientific Officer. “Ethicon continues to work with surgeons around the world and across specialties to design innovations to help surgeons deliver the best outcomes based on the unique needs of their patients and procedures.”

Related Links:

Ethicon Endo-Surgery



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.